Dynex Capital, Inc.
NYSE:DXREIT - Mortgage
+$0.09 today
- Market cap
- $2.52B
- Beta
- 0.93
- P/E (TTM)
- 10.9
- EPS (TTM)
- $1.21
- Dividend yield
- 15.53%
Volume 6.96M
Average 5.25M
DX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Dynex Capital, Inc.NYSE: DX
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How DX compares with its peers on the latest reported figures
- DX's LTM Sep 2026 research & development of $0 is the 3rd highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for DX, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $6.31M | — | — | 3.6% | |
| LTM Mar 2026 | $200K | +0.0% | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | -100.0% | +0.2% | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding DX) | $0 | -50.0% | +0.2% | 0.0% | |
Competitors are the stored peer set for DX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 66.76M | (2.37M) | 132.6M | 318.03M | 533.52M |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 66.76M | (2.37M) | 132.6M | 318.03M | 533.52M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 24.09M | 32.35M | 30.73M | 34.59M | 0 |
| Operating Expenses | (41.18M) | (189.15M) | (76.72M) | (109.53M) | (204.71M) |
| Depreciation & Amortization | 2.31M | 2.35M | 2.32M | 1.87M | 2.1M |
| EBITDA | 110.24M | 189.13M | 211.63M | 429.42M | 740.33M |
| EBITDA Margin | 165.1% | -7973.3% | 159.6% | 135.0% | 138.8% |
| Operating Income | 107.93M | 186.77M | 209.32M | 427.56M | 738.23M |
| Operating Margin | 161.7% | -7874.1% | 157.9% | 134.4% | 138.4% |
| Interest Income | 60.05M | 86.7M | 207.52M | 319.53M | 533.52M |
| Interest Expense | 5.67M | 43.61M | 215.45M | 313.66M | 419.17M |
| Other Income / Expenses | (5.67M) | (43.61M) | (215.45M) | (313.66M) | (419.17M) |
| Income Before Tax | 102.26M | 143.16M | (6.13M) | 113.9M | 319.07M |
| Pre-Tax Margin | 153.2% | -6035.5% | -4.6% | 35.8% | 59.8% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | 102.26M | 143.16M | (6.13M) | 113.9M | 319.07M |
| Net Margin | 153.2% | -6035.5% | -4.6% | 35.8% | 59.8% |
| EPS (Basic) | 2.78 | 3.19 | (0.25) | 1.50 | 2.49 |
| EPS (Diluted) | 2.78 | 3.17 | (0.25) | 1.49 | 2.47 |
| Weighted Avg Shares | 32.76M | 42.49M | 54.81M | 70.77M | 124.13M |
| Weighted Avg Shares (Diluted) | 32.76M | 42.74M | 54.81M | 71.26M | 125.07M |
Dynex Capital, Inc.
NYSE:DX
Intrinsic Alpha fair value
Locked
Current Price
$9.72
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.